Go Deep
IRulya Therapeutics Inc.
IRulya Therapeutics Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -17,167 | -0.1 | -0.96 | -0.52 | 3,147.38 |
| Oct 2026 | -17,144 | -0.1 | -0.92 | -0.52 | 3,033.72 |
| Oct 2026 | -19,392 | -0.2 | -0.99 | -0.52 | 3,266.42 |
| Oct 2026 | -19,507 | -0.2 | -1.16 | -0.52 | 3,818.26 |
| Oct 2026 | -19,396 | -0.2 | -1.00 | -0.52 | 3,280.11 |
| Oct 2026 | -19,359 | -0.2 | -0.94 | -0.52 | 3,098.85 |
IRulya Therapeutics Inc. Quarterly Results
Quarterly data isn't available for this company right now.
IRulya Therapeutics Inc. Revenue & Profit
Annual financial data isn't available for this company right now.
IRulya Therapeutics Inc. Balance Sheet
Balance sheet data isn't available for this company right now.
Owes vs Owns
IRulya Therapeutics Inc. owed $1.28 for every $1 it owned in Jun 2026, up from $0.03 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 1.28× | 1.38× | 0.74× | 0.49× | 0.03× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
IRulya Therapeutics Inc. Cash Flow
Cash flow data isn't available for this company right now.